Berry’s digital closure supports improved medicine adherence
Berry Global has launched a child-resistant closure that integrates digital technology to improve medication adherence: The new Berry Digi-Cap digital child-resistant closure is claimed to be ideal for clinical trials, drug development, research and academic studies. Patient behaviour data is analysed to enhance medicine adherence and gain insights into its effectiveness
Read more